Strong Men, Strong Communities Diabetes Risk Reduction in American Indian Men
| Status: | Recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 18 - 65 |
| Updated: | 7/19/2018 |
| Start Date: | June 15, 2018 |
| End Date: | July 31, 2021 |
| Contact: | Kaimi A Sinclair, PhD, MPH |
| Email: | kaimi.sinclair@wsu.edu |
| Phone: | 206-708-8633 |
Strong Men, Strong Communities: Cultural Tradition to Improve Native Men's Health
SMSC will inform the design and implementation of culturally informed, community-based
lifestyle interventions for diabetes prevention in AI men in our partner communities and
elsewhere, as well as in men of other minority groups who experience a heavy burden of
diabetes.
lifestyle interventions for diabetes prevention in AI men in our partner communities and
elsewhere, as well as in men of other minority groups who experience a heavy burden of
diabetes.
American Indian (AI) males experience profound health disparities compared to their
counterparts in all other U.S. racial and ethnic groups. AI men have the highest age-adjusted
prevalence of type 2 diabetes (~18%) among U.S. men, while non-Hispanic White men have the
lowest (~7%). In recent decades, AIs have seen a disproportionate increase in
diabetes-related complications and mortality compared to all other groups, such that
age-adjusted diabetes death rates in AI men are now almost twice those in White men.
Several large randomized, con trolled trials in non-AIs confirm that type 2 diabetes can be
prevented or delayed by interventions that promote healthy lifestyles, but little empirical
data exist on interventions to prevent diabetes in AI men. In the clinic-based U.S. Diabetes
Prevention Program (DPP), only 55 out of 3,234 participants were AI men. Similarly, in the
diabetes prevention programs in Native communities, participation by AI males is low, ranging
from 33% to 74%. Many explanations have been posited for the low participation rates among
men of all races in lifestyle interventions. Recruiting AI men in clinic-based programs is
difficult because they tend to seek clinical care less often than women. AI men's perceptions
of normative health behaviors and gender roles may also discourage participation,
particularly in mixed-gender groups. Therefore, an urgent need exists for diabetes risk
reduction programs tailored to the unique values and habits of AI men, with a particular
focus on recruitment and retention
counterparts in all other U.S. racial and ethnic groups. AI men have the highest age-adjusted
prevalence of type 2 diabetes (~18%) among U.S. men, while non-Hispanic White men have the
lowest (~7%). In recent decades, AIs have seen a disproportionate increase in
diabetes-related complications and mortality compared to all other groups, such that
age-adjusted diabetes death rates in AI men are now almost twice those in White men.
Several large randomized, con trolled trials in non-AIs confirm that type 2 diabetes can be
prevented or delayed by interventions that promote healthy lifestyles, but little empirical
data exist on interventions to prevent diabetes in AI men. In the clinic-based U.S. Diabetes
Prevention Program (DPP), only 55 out of 3,234 participants were AI men. Similarly, in the
diabetes prevention programs in Native communities, participation by AI males is low, ranging
from 33% to 74%. Many explanations have been posited for the low participation rates among
men of all races in lifestyle interventions. Recruiting AI men in clinic-based programs is
difficult because they tend to seek clinical care less often than women. AI men's perceptions
of normative health behaviors and gender roles may also discourage participation,
particularly in mixed-gender groups. Therefore, an urgent need exists for diabetes risk
reduction programs tailored to the unique values and habits of AI men, with a particular
focus on recruitment and retention
Inclusion Criteria:
- Must be male and self-reported American Indian; ages 18-65, A BMI ≥25 kg/m2 and/or a
waist circumference >90 cm for men; no prior diabetes diagnosis; No history of heart
disease, serious illness, cancer diagnosis in the last five years, or other conditions
that may impede or prohibit participation; and, willingness to consent to
randomization
Exclusion Criteria:
- Females, under 18 years old or older than 65 years
We found this trial at
1
site
